MARKET

BIO

BIO

Bio Rad Labs Inc
NYSE
326.16
-2.35
-0.72%
After Hours: 326.16 0 0.00% 16:05 01/02 EST
OPEN
330.19
PREV CLOSE
328.51
HIGH
335.79
LOW
324.56
VOLUME
108.63K
TURNOVER
--
52 WEEK HIGH
386.54
52 WEEK LOW
262.12
MARKET CAP
9.13B
P/E (TTM)
-11.9375
1D
5D
1M
3M
1Y
5Y
1D
Implied FELV Analyst Target Price: $35
NASDAQ · 12/30/2024 14:31
Weekly Report: what happened at BIO last week (1223-1227)?
Weekly Report · 12/30/2024 09:29
Weekly Report: what happened at BIO last week (1216-1220)?
Weekly Report · 12/23/2024 09:30
How Is Bio-Techne’s Stock Performance Compared to Other Biotechnology Stocks?
Barchart · 12/23/2024 08:27
Benjamin Graham Detailed Fundamental Analysis - BIO
NASDAQ · 12/20/2024 21:00
Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?
Simply Wall St · 12/16/2024 18:06
Weekly Report: what happened at BIO last week (1209-1213)?
Weekly Report · 12/16/2024 09:31
Broad Market Gains Shape Moat Strategies For 2025
Seeking Alpha · 12/11/2024 10:20
More
About BIO
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Its Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes and food testing regimes. The Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are primarily sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.

Webull offers Bio Rad Laboratories Inc stock information, including NYSE: BIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BIO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BIO stock methods without spending real money on the virtual paper trading platform.